Skip to main content

Table 1 Group distribution and CT analysis

From: Bone augmentation for cancellous bone-development of a new animal model

Group Number of animals Material CT Clinical signs of pulmonary embolism
1 6 FS + MP1 + CA, with/without BM4 1 1
2 7 FS + CA, with/without BM4   
3 5 control/sham 2  
4 6 FS + MP2 + CA, with/without BM4   
5 6 FS + MP2 + CA, with/without BM4   
6 6 FS + CA, with/without BM4   
7 5 FS + MP2 + BM1 5  
8 5 FS + MP2 + BM2 4  
9 5 FS + MP2 + BM3 4 1
10 2 FS + MP2 + BM4   
11 5 FS + MP2 + BM5 2 1
12 5 FS + MP2 + BM6 1 1
  1. Legend:
  2. FS: Fibrin-scaffold.
  3. MP1 or 2: Mineral powder 1 or 2.
  4. CA: Contrast agent.
  5. BM1-6: Biomimetic agent concentration 1-6.
  6. with/without: One leg with and one leg without BM4.
  7. This table shows the group distribution of all animals including the numbers of CT’s performed in each treatment group as well as the numbers of animals with cardiovascular complications occurring during surgery.